A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine
Clinical trial NCT06291857 · COMPLETED
Trial details
- NCT number
- NCT06291857
- Sponsor
- Novavax
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-09
- Primary completion
- 2025-12-24
- Enrollment
- 9320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.